Welcome to the Rahme Laboratory 

The Rahme lab investigates how epigenetic and chromatin architectural disruptions rewire gene regulation to drive glioma development. Our research integrates epigenomics, functional epigenome editing, and in vivo cancer models to uncover early, causative lesions that drive malignant transformation and tumor progression.  

Our long-term goal is to translate fundamental insights of genome regulation into new strategies for cancer diagnosis and therapy.

We welcome inquiries from highly-motivated students and postdoctoral fellows. Please contact us to inquire.